off
Raptor Pharma says may discontinue development of liver drug
Shares of Raptor Pharmaceuticals plunged 35.5 percent in premarket trading today. The company has a market cap of $977 million and there are 81,180,000 shares in outstanding.
Posted On Sep 15 2015
